Little Rock, Arkansas

Little Rock is a rising life sciences hub defined by a collaborative ecosystem that fuses academic research with industry-leading healthcare innovation.

At the center of this growth is the University of Arkansas for Medical Sciences (UAMS), a powerhouse for translational medicine and biomedical research that ranks in the top tier of US institutions for federal funding. The city is globally recognized for its expertise in oncology and genomics, specifically through the Winthrop P. Rockefeller Cancer Institute and the world-renowned Myeloma Center.

Complementing this academic strength, the Arkansas Children’s Research Institute drives significant advancements in pediatric therapeutics and clinical trials, making Little Rock a critical site for specialized drug development.

The region’s biotechnology sector is bolstered by a thriving network of startups and established firms focused on bioinformatics, diagnostics and precision medicine.

In the medical device space, Little Rock serves as a fertile ground for medtech innovation, supported by accelerators like HealthTech Arkansas which facilitate hospital-based pilot projects.

The city's healthcare infrastructure is further enhanced by the Institute for Digital Health & Innovation, which leads the nation in telemedicine and remote patient monitoring.

By integrating AI-driven diagnostics in clinical settings and fostering a robust bio-manufacturing pipeline, Little Rock provides a scalable, cost-effective environment for global biopharma companies to expand.

This unique "convergence" culture ensures that external companies, local researchers and life science startups work together to accelerate the path from lab to market.

Ultimately, Little Rock’s commitment to health technology and specialized care makes it an essential destination for global stakeholders in the life sciences industry.